Russell A Shatford

Title: Russell A. Shatford: Innovator in Bioreactor Technology

Introduction

Russell A. Shatford is a notable inventor based in Minneapolis, MN (US). He has made significant contributions to the field of bioreactor technology, particularly in the maintenance of animal cells for various medical applications. With a total of 2 patents, his work focuses on enhancing cell viability and function.

Latest Patents

Shatford's latest patents include innovative methods for maintaining cells for extended periods through entrapment. One of his patents describes a bioreactor designed to support hepatocyte function and viability, which is crucial for treating patients suffering from hepatic failure. This bioreactor features a feed and waste chamber, along with a cell chamber separated by a selectively permeable membrane. Within the cell chamber, a biocompatible contracted three-dimensional gel matrix entraps animal cells, allowing for the preservation of tissue-specific functions. The bioreactor can be configured as either hollow fiber or flat-bed, optimizing the conditions for cell growth and product production.

Another patent focuses on a bioreactor apparatus that utilizes a similar two-chamber design. This apparatus also employs a biocompatible matrix to create distinct gel and liquid phases, facilitating the harvesting of concentrated cell products. The innovative design allows for efficient nutrient perfusion and waste removal, making it a promising solution for bioartificial liver applications.

Career Highlights

Russell A. Shatford is affiliated with the University of Minnesota, where he continues to advance research in bioreactor technology. His work has garnered attention for its potential to improve treatment options for patients with liver conditions.

Collaborations

Shatford has collaborated with esteemed colleagues such as Wei-Shou Hu and Frank B. Cerra, contributing to the advancement of biotechnological innovations.

Conclusion

Russell A. Shatford's contributions to bioreactor technology exemplify the intersection of innovation and medical application. His patents reflect a commitment to enhancing cell viability and function, paving the way for future advancements in healthcare.